[en] OBJECTIVE: The feasibility of large-scale Down syndrome maternal screening with dried blood samples and nonradioactive methods was examined. STUDY DESIGN: A prospective observation study was performed on a nonselected population of 11,241 pregnant women sampled between January 1991 and September 1992, between 14 and 24 weeks' gestation (ultrasonographic scanning available for 91.6%), through a multicenter collaborative network. Enzyme-linked immunosorbent assays for alpha-fetoprotein, human chorionic gonadotropin, and free estriol were performed on dried blood samples. Risk determination was made with an in-house software implementing the multivariate gaussian log likelihood method. RESULTS: A total of 10,450 samples were eligible for the study. Mean age at term was 27.9 years. A total of 6.84% of the patients were > or = 35 years old with a prior risk of trisomy 21 > 1:350. The general positive rate of our sample was 8.15%. After calculation 31.7% with prior risk > 1:350 were still in the high-risk group; 6.36% of the low-risk group were found to be at high risk for Down syndrome. Fifteen trisomic pregnancies were observed, of which 11 had a calculated risk higher than the selected cutoff value (1:350). The overall detection rate was 73%, specificity was 92%, and positive predictive power was 1.2%. CONCLUSION: Our pilot study has shown performances within the range of conventional serum screening programs. Dried blood assays are a handy alternative to serum assays. Blot paper cards represent a simple method of sampling, well fitted for large population screening. Combined with nonradioactive methods, this method appears to be both low cost and effective. The current work apparently is the first large-scale Down screening program performed with dried blood.
Disciplines :
Genetics & genetic processes
Author, co-author :
Verloes, Alain ; Université de Liège - ULiège > Génétique générale et humaine
Schoos, Roland ; Centre Hospitalier Universitaire de Liège - CHU > Génétique
Herens, Christian ; Centre Hospitalier Universitaire de Liège - CHU > PLAN COS
Vintens, A.
Koulischer, Lucien ; Université de Liège - ULiège > Relations académiques et scientifiques (Médecine)
Language :
English
Title :
A Prenatal Trisomy 21 Screening Program Using Alpha-Fetoprotein, Human Chorionic Gonadotropin, and Free Estriol Assays on Maternal Dried Blood
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Young, Gregson, Jacob (1991) The efficacy of maternal age screening for Down's syndrome in Wessex. Prenatal Diagnosis 11:419-425.
Merkatz, Nitowsky, Macri, Kranz (1984) An association between low serum α-fetoprotein and fetal chromosome abnormalities. Am J Obstet Gynecol 148:886-894.
Cuckle, Wald, Lindenbaum (1984) Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet 1:926-929.
Cuckle, Wald, Thompson (1987) Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94:387-392.
Milunsky, Nebiolo (1992) Screening for chromosome defects in the first and second trimesters of pregnancy. Maternal serum sampling for fetal genetic disorders , S Elias, JL Simpson, Churchill Livingstone, New York; 75-85.
Canick, Knight, Palomaki, Haddow, Cuckle, Wald (1988) Low second trimester serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol 95:330-333.
Wald, Cuckle, Densem (1988) Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol 95:334-341.
Bogart, Pandian, Jones (1987) Abnormal maternal serum chorionic gonadotrophin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 7:623-630.
Macri, Katsuri, Krantz, Cook, Sunderji, Larsen (1990) Maternal serum Down syndrome screening: free β-protein is a more effective marker than human chorionic gonadotropin. Am J Obstet Gynecol 163:1248-1253.
Wald, Cuckle, Densem (1988) Maternal serum screening for Down's syndrome in early pregnancy. BMJ 297:883-887.
Verloes, Schoos, Koulischer (1992) Non-radioactive assay of AFP, hCG, and uE3 from dried blood specimens: a low-cost alternative for maternal screening for trisomy 21. Prenat Diagn 12:1073-1074.
Haddow, Palomaki, Knight, Canick, Wald, Cuckle (1990) Maternal serum unconjugated estriol levels are lower in the presence of fetal Down syndrome. Am J Obstet Gynecol 163:1372-1373.
Palomaki, Knight, Holman, Haddow (1990) Maternal serum α-fetoprotein screening for fetal Down syndrome in the United States: result of a survey. Am J Obstet Gynecol 162:317-321.
Cuckle, Wald (1992) HCG, estriol, and other maternal blood markers of fetal aneuploidy. Maternal serum screening for fetal genetic disorders , S Elias, JL Simpson, Churchill Livingstone, New York; 87-107.
Haddow, Palomaki, knight (1992) Prenatal screening for Down syndrome with use of maternal serum markers. N Engl J Med 327:588-593.
Heyl, Miller, Canick (1990) Maternal serum screening for aneuploid pregnancies by alpha-fetoprotein, hCG, and unconjugated estriol. Obstet Gynecol 76:1025-1031.
Kelly, Lee, Petrocik, Wassman (1989) Prenatal Down syndrome screening using a combinational analysis of maternal age, serum alpha fetoprotein and serum human gonadotrophin. Am J Hum Genet , [Abstract]; 45:A262.
McDonald, Wagner (1990) Maternal serum screening with AFP, hCG and oestriol: retrospective and prospective results. Am J Hum Genet , [Abstract]; 47:A281.
McDonald, Wagner, Slotnick (1991) Sensitivity and specificity of screening for Down's syndrome with alphafetoprotein, hCG, unconjugated estriol and maternal age. Obstet Gynecol 77:63-68.
Phillips, Elias, Shulman, Andersen, Morgan, simpson (1992) Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. Obstet Gynecol 80:353-358.
Ryall, Staples, Robertson, Pollard (1992) Improved performance in a prenatal screening programme for Down's syndrome incorporating serum-free hCG subunit analysis. Prenat Diagn 12:251-261.
Wald, Kennard, Densem, Cuckle, Chard, Butler (1992) Antenatal maternal serum screening for Down syndrome: results of a demonstration project. BMJ 305:391-394.
Mancini, Perona, Dall'Amico, Bollati, Fulvia, Carbonara (1992) hCG, AFP, and uE3 patterns in the 14-20th weeks of Down's syndrome pregnancies. Prenat Diagn 12:619-624.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.